Efficacy and Safety of Canakinumab in Schnitzler Syndrome

Clinical trial NCT01276522 · COMPLETED

Trial details

NCT number: NCT01276522
Sponsor: Radboud University Medical Center
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Schnitzler Syndrome

Start date: 2011-01-01
Primary completion: 2011-05-01
Enrollment: 8

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.